Osteoporosis is a decrease in bone mass and strength causing susceptibility to fractures. It is the major cause of bone fractures in postmenopausal women and older persons in general. Osteoporosis has no clear beginning, and until recently its first visible sign was a debilitating fracture of the hip, wrist, or vertebral bodies causing pain or deformity.
A young woman (P.A.) suffered from back pain for almost 2 years before contacting our Bone Metabolic Unit in 1996. She was a beautiful South-Italian woman, 26 years old, with dark eyes, dark hair, and an olive complexion.
To get enough calcium for growing bones, each day you need to eat foods whose %Daily Value for calcium adds up to 120 percent. Because the amount of calcium in foods can vary, read the food label check the %DV for calcium in what you eat.
Gene Expression Analysis in Human Osteoblasts Exposed to Dexamethasone Identifies Altered Developmental Pathways as Putative Drivers of Osteoporosis
During the two recent decades, advocacy has been a topic of much debate in the nursing profession. Although advocacy has embraced a crucial role for nurses, its extent is often limited in practice.
The Impact of Vitamin D Status on Changes in Bone Mineral Density During Treatment with Bisphosphonates and AfterDiscontinuation Following Long-term Use in Post-menopausal Osteoporosis
Osteoporotic fractures are common and are associated with increased morbidity, mortality and health care costs. The most effective way to moderate increases in health care costs and the sickness and premature death associated with osteoporotic fractures, is to prevent osteoporosis.
In this era of constrained health-care resources, a critical need exists for efficient, measurable systems of disease management that strike a balance between social responsibility and patient welfare.
Bone is continuously remodeled through a coupled process of bone resorption and formation.
Along with three cups of milk, have a serving or two of any of these foods to get more than 1,000 milligrams of calcium.
Osteoporosis is recognized as a significant contributor to morbidity and mortality in postmenopausal women. Several effective strategies, including calcium supplementation, weight-bearing exercise, and, most importantly, hormone replacement, have been developed to prevent or at least delay clinically significant bone loss.
-University of Cincinnati Launches Program to Help Close the Knowledge Gap-
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), between 30 and 50 million Americans are lactose intolerant.
Hormone Replacement Therapy in Postmenopausal Women: Urinary N-Telopeptide of Type I Collagen Monitors Therapeutic Effect and Predicts Response of Bone Mineral Density
Preliminary Results of the Sunlight OmnisenseTM Bone Sonometer: In-vivo and In-vitro Precision and Correlation with DXA.
Hyperthyroidism in postmenopausal women is associated with accelerated bone loss that results in lower BMD as detected by DEXA, SPA, QCT as well as bone markers’ levels. However, there is no data of QUS evaluation in thyrotoxic patients.
Vertebral fracture is usually the earliest clinical manifestation of severe osteoporosis. Early detection of vertebral fracture risk is therefore crucial for prevention and treatment of osteoporosis.
In a recent study of women with repeated miscarriages and fibroids, researchers found that removing them significantly increased the live birth rate. This increase was noted with both fibroids that distorted the uterine cavity as well as those that did not.
Diethylstilbestrol, or DES, a synthetic form of estrogen, was prescribed from the early 1940s until 1971 to help women with certain complications of pregnancy, primarily miscarriages. Use of DES declined in the 1960s after studies showed that it might not be effective in preventing pregnancy complications.
Infertility is a disease that affects the reproductive organs of both men and women. It impairs one of the body’s most basic functions: the ability to have children. Infertility affects about 6.1 million people in the United States alone; ten percent of the reproductive-age population-both men and women.
The following statements are a general consensus and my personal view, but takes into account the establishment of a correct diagnosis of PCOS, the probability of combined complaints, and the presence or absence of a significant associated adrenal androgen hormonal production.
On December 1, 2010, the Institute of Medicine released its 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D. One of its authors, JoAnn E. Manson, MD, DrPH, agreed to answer some questions for NAMS.
Osteoporosis is an enormous public health problem. Twenty-eight million Americans suffer from this disease, a condition which can cause crippling fractures. It is the major cause of disability among American women. However, while there is no cure for osteoporosis, it is important to remember that proper treatment can help stop further bone loss and prevent fractures.
Osteoporosis --meaning porous, fragile bones --is a disease in which there is exaggerated loss of quantity and quality of bone, causing an increase in the risk of fractures. It's normal for the bones of both women and men to get thinner and more fragile with age.
Osteoporosis is a disease that is caused by significant bone loss, which leaves the bones weak and at an increased risk for fracture. It is diagnosed clinically when a patient has a history of certain types of fractures, or by the use of special X-ray studies such as a DEXA scan.
In humans, serotonin has typically been investigated as a neurotransmitter. However, serotonin also functions as a hormone across animal phyla, including those lacking an organized central nervous system. This hormonal action allows serotonin to have physiological consequences in systems outside the central nervous system. Fluctuations in estrogen levels over the lifespan and during ovarian cycles cause predictable changes in serotonin systems in female mammals.
Osteoporosis results in fractures and treatment of osteoporosis has been shown to reduce risk of fracture particularly in those who have had a history of fracture.
Fracture represents the single most important clinical event in patients with osteoporosis, yet remains under-predicted. As few premonitory symptoms for fracture exist, it is of critical importance that physicians effectively and efficiently identify individuals at increased fracture risk.
By some estimates, as many as 80% of women will have fibroids at some point in their lives. And, although many women are asymptomatic, their presence can cause extreme pain in some women and also may be a factor in infertility issues, with submucosal, intramural and subserosal fibroids (in a decreasing order of importance) impacting infertility. Moreover, some research has linked the presence of uterine fibroids with recurrent miscarriage in women, but the data thus far had been inconclusive.